The unit aims to enable students to make progress towards meeting some of the learning outcomes described in 'Outcome for Graduates' (2018) relevant to 'The Doctor as a Scholar and Scientist' and 'The Doctor as a Practitioner'. The specific aim is to enable students to develop knowledge of pharmacodynamics and pharmacokinetics that will allow them to develop an understanding of pharmacological options of therapy. The predominantly scientific knowledge gained in this module will be combined with safe prescribing training in CSFC and medical blocks in Phase II to be able to manage pharmacotherapy of patients at an appropriate level.

The unit aims to enable students to make progress towards meeting some of the learning outcomes described in Outcomes for Graduates (2018) relevant to 'The Doctor as a Scholar and Scientist', 'The Doctor as a Practitioner' and 'The Doctor as a Professional'.  The specific aim is to enable students to develop skills of integrating understanding and focussing that integrated understanding on problems presented by patients.

The unit aims to enable students to make progress towards meeting some of the learning outcomes described in the GMC’s Outcomes for Graduates (2018) relevant to “Professional values and behaviours” and “Professional knowledge”.  The specific aims are to enable students to carry out a patient-centred consultation and interpret the findings to generate appropriate working diagnoses and to enable students to take and record a history from a patient, perform a physical examination of the main systems of the body and understand the importance of the patient perspective in diagnosing and managing patient problems.

The unit aims to enable students to make progress towards meeting some of the learning outcomes described in Tomorrow’s Doctors (2018) relevant to ‘The Doctor as a Scholar and Scientist’, ‘The Doctor as a Practitioner’ and ‘The Doctor as a Professional’. The specific aim is to help students bring together their knowledge and skills in preparation for full time clinical study in Phase 2, through a set of extended case studies relating to common clinical conditions.